567
Views
11
CrossRef citations to date
0
Altmetric
Cardiovascular

Oral anticoagulation therapy and subsequent risk of venous thromboembolism in atrial fibrillation patients

, , , , , , & show all
Pages 837-845 | Received 08 May 2018, Accepted 24 Oct 2018, Published online: 03 Dec 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

William L. Baker, Matthew S. Roberts, Youssef Bessada, Kimberly S. Caroti, Veronica Ashton, Brahim K. Bookhart & Craig I. Coleman. (2023) Comparative outcomes associated with rivaroxaban versus warfarin use in elderly patients with atrial fibrillation or acute venous thromboembolism managed in the United States: a systematic review of observational studies. Current Medical Research and Opinion 39:9, pages 1183-1194.
Read now

Articles from other publishers (10)

Daniele Pastori, Gianluca Gazzaniga, Alessio Farcomeni, Tommaso Bucci, Danilo Menichelli, Giovanni Franchino, Arianna Pani, Francesco Violi, Pasquale Pignatelli, Laurent Fauchier & Gregory Y.H. Lip. (2023) Venous Thromboembolism in Patients With Atrial Fibrillation. JACC: Advances 2:7, pages 100555.
Crossref
A. A. Sokolova, A. A. Kudriavtseva, N. V. Kostokova, M. P. Zaikina, Z. A. Gebekova, D. A. Napalkov & I. A. Zolotukhin. (2022) Risk of Venous Thromboembolic Complications in Patients with Atrial Fibrillation: a Systematic Review and Meta-analysis. Rational Pharmacotherapy in Cardiology 18:3, pages 236-241.
Crossref
Zhiyan Liu, Lingyue Ma, Hanxu Zhang, Guangyan Mu, Qiufen Xie, Shuang Zhou, Zining Wang, Zhe Wang, Kun Hu, Yanjun Gong, Jie Jiang, Qian Xiang & Yimin Cui. (2021) Comparison of non‐vitamin K antagonist oral anticoagulants on bleeding and thrombosis. Journal of Clinical Pharmacy and Therapeutics 46:6, pages 1729-1742.
Crossref
A.A. Kulkarni, N. Rubin, A. Tholkes, S. Shah, C.J. Ryan, P.L. Lutsey, A. Prizment & A. Rao. (2021) Risk for stroke and myocardial infarction with abiraterone versus enzalutamide in metastatic prostate cancer patients. ESMO Open 6:5, pages 100261.
Crossref
Dishiwen Liu, Shaobo Shi, Xin Liu, Tianxin Ye, Linglin Wang, Chuan Qu, Bo Yang & Qingyan Zhao. (2021) Retrospective cohort study of new-onset atrial fibrillation in acute pulmonary embolism on prognosis. BMJ Open 11:9, pages e047658.
Crossref
Eveline M Bunge, Ben van Hout, Sylvia Haas, Georgios Spentzouris & Alexander Cohen. (2021) Critical appraisal and issues regarding generalisability of comparative effectiveness studies of NOACs in atrial fibrillation and their relation to clinical trial data: a systematic review. BMJ Open 11:2, pages e042024.
Crossref
Thure Filskov Overvad, Flemming Skjøth, Ida Ehlers Albertsen, Torben Bjerregaard Larsen, Mette Søgaard & Gregory Y.H. Lip. (2021) Should We Reintroduce Previous Venous Thromboembolism Into Decision-Making for Anticoagulation in Atrial Fibrillation?. The American Journal of Medicine 134:1, pages 67-75.e5.
Crossref
Miho Ishimaru. (2020) Introduction to High-dimensional Propensity Score Analysis. Annals of Clinical Epidemiology 2:4, pages 85-94.
Crossref
Behnood Bikdeli & David Jiménez. (2019) Atrial fibrillation in the course of pulmonary embolism: just a little smoke, or fuel to the fire?. Journal of Internal Medicine 287:1, pages 114-116.
Crossref
Pamela L. Lutsey, Neil A. Zakai, Richard F. MacLehose, Faye L. Norby, Rob F. Walker, Nicholas S. Roetker, Terrence J. Adam & Alvaro Alonso. (2019) Risk of hospitalised bleeding in comparisons of oral anticoagulant options for the primary treatment of venous thromboembolism. British Journal of Haematology 185:5, pages 903-911.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.